Junyuan Wang's Insider Trades & SAST Disclosures
Junyuan Wang's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 56,361 Class A Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on Nov. 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Junyuan Wang.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 11 Nov 2024 | 56,361 | 3,866,228 | - | 2.9 | 162,883 | Class A Common Stock | |
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 03 Sep 2024 | 2,543,600 | 3,922,589 | - | - | Class A Common Stock | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 03 Sep 2024 | 1,695,700 | 2,246,458 | - | - | Class A Common Stock | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 03 Sep 2024 | 86,471 | 86,471 | - | - | Warrants (Right to Buy) | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 03 Sep 2024 | 57,647 | 57,647 | - | - | Warrants (Right to Buy) | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 03 Sep 2024 | 25,436 | 0 | - | - | Series A Preferred Stock | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 03 Sep 2024 | 25,436 | 25,436 | - | - | Series A Preferred Stock | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 03 Sep 2024 | 16,957 | 0 | - | - | Series A Preferred Stock | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 03 Sep 2024 | 16,957 | 16,957 | - | - | Series A Preferred Stock | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 09 Apr 2024 | 1,378,989 | 1,378,989 | - | 0 | Class A Common Stock | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 09 Apr 2024 | 550,758 | 550,758 | - | 0 | Class A Common Stock | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 09 Apr 2024 | 486,669 | 486,669 | - | - | Stock Option (Right to Buy) | ||
| Nuvation Bio Inc - Ordinar... | Junyuan Wang | Director, CEO, ANHEART THERAPEUTICS LTD. | 09 Apr 2024 | 388,299 | 388,299 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges